Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Isoray, Inc. ISR
$0.38
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
0.45
-
week52low
0.19
-
Revenue
10795000
-
P/E TTM
-6
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Northland Capital Markets | Outperform | 14 сент 2021 г. | |
| HC Wainwright & Co. | Buy | Buy | 10 февр 2021 г. |
| Oppenheimer | Outperform | 16 дек 2020 г. | |
| H.C. Wainwright | Buy | 12 февр 2020 г. | |
| Maxim Group | Hold | Buy | 09 ноя 2018 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Hunt Jonathan Robert | A | 191710 | 32200 | 05 дек 2022 г. |
| Hunt Jonathan Robert | A | 159510 | 53204 | 01 дек 2022 г. |
| Woods Lori A | A | 1147038 | 100000 | 15 ноя 2022 г. |
| Streeter Jennifer | D | 0 | 50000 | 18 авг 2022 г. |
| Streeter Jennifer | A | 77940 | 50000 | 18 авг 2022 г. |
| Streeter Jennifer | A | 87940 | 50000 | 18 авг 2022 г. |
| Austin Mark John | A | 548115 | 150000 | 09 авг 2022 г. |
| Streeter Jennifer | D | 0 | 22500 | 05 авг 2022 г. |
| Streeter Jennifer | A | 27940 | 22500 | 05 авг 2022 г. |
| Cavanagh William | A | 1493846 | 475000 | 21 июл 2022 г. |
Новостная лента
IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates
Zacks Investment Research
16 февр 2023 г. в 18:49
IsoRay (ISR) delivered earnings and revenue surprises of -100% and 56.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Isoray, Inc. (ISR) Q1 2023 Earnings Call Transcript
Seeking Alpha
10 ноя 2022 г. в 18:55
Isoray, Inc. (NYSE:ISR ) Q1 2023 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Thijs Spoor - CEO, Viewpoint Molecular Targeting Jonathan Hunt - CFO Conference Call Participants Mike Ott - Oppenheimer Operator Good day, ladies and gentlemen. And welcome to the Isoray, Inc. Q1 FY 2023 Call.
Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022
GlobeNewsWire
31 окт 2022 г. в 08:14
Conference Call is Thursday, November 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT Conference Call is Thursday, November 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT
Business Wire
18 окт 2022 г. в 16:30
RICHLAND, Wash.
Isoray, Inc. (ISR) Q4 2022 Earnings Call Transcript
Seeking Alpha
28 сент 2022 г. в 22:35
Isoray, Inc. (NYSE:ISR ) Q4 2022 Earnings Conference Call September 28, 2022 4:30 PM ET Company Participants Mark Levin - Investor Relations Lori Woods - Chief Executive Officer Thijs Spoor - Chief Executive Officer, Viewpoint Molecular Targeting Jonathan Hunt - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Mike Ott - Oppenheimer Operator Good afternoon, ladies and gentlemen. And welcome to the Isoray, Inc. Fourth Quarter Fiscal Year 2022 Call.